IDEAS home Printed from https://ideas.repec.org/h/spr/isbchp/978-981-10-1684-4_6.html
   My bibliography  Save this book chapter

Does M&A Matter for R&D? Evidence from the Pharmaceutical Sector in India

In: Technology

Author

Listed:
  • Vidhisha Vyas

    (IILM Institute of Business and Management)

  • K. Narayanan

    (IIT)

Abstract

It is widely accepted that technological expertise, market know-how, tacit knowledge and quick innovation are crucial corporate assets for facing increased competition. Mergers and acquisitions [M&A] has become a means for firms to acquire, absorb and exploit the knowledge assets of target firm. The present study investigates the relationship between M&A and innovation activities of pharmaceutical firms (post-M&A R&D intensity) for three post acquisition years and for average of three years. To analyze the impact, appropriate acquirer’s characteristics have been drawn from learning and innovation theory and financial economics theory. The findings of the paper suggest that acquisitions per se have a mixed impact on R&D intensity of firms in immediate post-acquisition years. Financial factors captured by leverage also appear to influence adversely the R&D intensity of acquiring firms. While technology imports through embodied capital goods boost acquiring firms’ R&D intensity, imports of disembodied technology lowers the need for R&D expenditure. Relatedness of target and acquiring firms and cross-border M&A, however, enhances R&D intensity in post-M&A period. This could imply that mergers and acquisitions of firms, if carried out in similar line of business, could boost innovative efforts in this industry in India.

Suggested Citation

  • Vidhisha Vyas & K. Narayanan, 2016. "Does M&A Matter for R&D? Evidence from the Pharmaceutical Sector in India," India Studies in Business and Economics, in: N.S. Siddharthan & K. Narayanan (ed.), Technology, pages 89-109, Springer.
    • Handle: RePEc:spr:isbchp:978-981-10-1684-4_6
    DOI: 10.1007/978-981-10-1684-4_6
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Unsal, Omer & Rayfield, Blake, 2019. "Institutional investors and medical innovation," The Quarterly Review of Economics and Finance, Elsevier, vol. 74(C), pages 190-205.
    2. Unsal, Omer, 2020. "Two faces of corporate lobbying: Evidence from the pharmaceutical industry," The North American Journal of Economics and Finance, Elsevier, vol. 51(C).
    3. Vissa, Siva Kameswari & Thenmozhi, M., 2022. "What determines mergers and acquisitions in BRICS countries: Liquidity, exchange rate or innovation?," Research in International Business and Finance, Elsevier, vol. 61(C).

    More about this item

    Keywords

    M&A; R&D intensity; Technology imports; Leverage; JEL classification: G34; C23; O32;
    All these keywords.

    JEL classification:

    • G34 - Financial Economics - - Corporate Finance and Governance - - - Mergers; Acquisitions; Restructuring; Corporate Governance
    • C23 - Mathematical and Quantitative Methods - - Single Equation Models; Single Variables - - - Models with Panel Data; Spatio-temporal Models
    • O32 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Management of Technological Innovation and R&D

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:isbchp:978-981-10-1684-4_6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.